Once-Daily Extended-Release Levetiracetam Improves Medication Compliance in Adolescent Epilepsy Patients
Purpose Since pharmacologic agents are the mainstay of epilepsy treatment, drug compliance is one of the most important factors in seizure control. Once-daily levetiracetam (LEV) has been proven to have the same efficacy as that of an immediate-release (IR) formulation. A reduced number of doses may...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Child Neurology Society
2021-04-01
|
| Series: | Annals of Child Neurology |
| Subjects: | |
| Online Access: | http://www.annchildneurol.org/upload/pdf/acn-2020-00290.pdf |